Su Phyu

624 total citations
20 papers, 243 citations indexed

About

Su Phyu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Su Phyu has authored 20 papers receiving a total of 243 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 7 papers in Immunology. Recurrent topics in Su Phyu's work include CAR-T cell therapy research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Su Phyu is often cited by papers focused on CAR-T cell therapy research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Metabolomics and Mass Spectrometry Studies (3 papers). Su Phyu collaborates with scholars based in United States, United Kingdom and Canada. Su Phyu's co-authors include Timothy Smith, Hideho Okada, Chih‐Chung Tseng, Ian N. Fleming, Eileen E. Parkes, David A. Scheiblin, Vincenzo Cerundolo, Richard J. Bryant, Said Alyacoubi and Akane Yamamichi and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Su Phyu

19 papers receiving 236 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Phyu United States 10 124 107 73 42 39 20 243
Zhizhong Wei China 10 84 0.7× 160 1.5× 105 1.4× 67 1.6× 19 0.5× 17 312
Masashi Kitazawa Japan 9 157 1.3× 96 0.9× 108 1.5× 55 1.3× 44 1.1× 12 341
Cai Sun China 8 84 0.7× 100 0.9× 52 0.7× 47 1.1× 11 0.3× 19 214
Alexandre Perrier France 6 81 0.7× 106 1.0× 24 0.3× 58 1.4× 38 1.0× 17 215
Allan D. Burrows Australia 7 126 1.0× 133 1.2× 98 1.3× 59 1.4× 33 0.8× 10 287
Andrea Favero Italy 7 60 0.5× 98 0.9× 31 0.4× 43 1.0× 45 1.2× 9 201
Satoshi Nemoto Japan 8 108 0.9× 165 1.5× 94 1.3× 15 0.4× 22 0.6× 17 325
Gunjan Dagar India 8 156 1.3× 129 1.2× 64 0.9× 25 0.6× 39 1.0× 16 283
Е. В. Кайгородова Russia 11 189 1.5× 122 1.1× 46 0.6× 87 2.1× 45 1.2× 41 333
Luca Paruzzo Italy 6 99 0.8× 71 0.7× 47 0.6× 24 0.6× 33 0.8× 12 192

Countries citing papers authored by Su Phyu

Since Specialization
Citations

This map shows the geographic impact of Su Phyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Phyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Phyu more than expected).

Fields of papers citing papers by Su Phyu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Phyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Phyu. The network helps show where Su Phyu may publish in the future.

Co-authorship network of co-authors of Su Phyu

This figure shows the co-authorship network connecting the top 25 collaborators of Su Phyu. A scholar is included among the top collaborators of Su Phyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Phyu. Su Phyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hatae, Ryusuke, Payal Watchmaker, Akane Yamamichi, et al.. (2025). Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model. Neuro-Oncology Advances. 7(1). vdaf074–vdaf074. 3 indexed citations
2.
Watchmaker, Payal, Ryusuke Hatae, Akane Yamamichi, et al.. (2025). Abstract 6104: Comparative evaluation of CAR-expressing T-, NK-, NKT-cells and macrophages in an immunocompetent mouse glioma model. Cancer Research. 85(8_Supplement_1). 6104–6104. 1 indexed citations
3.
Phyu, Su, et al.. (2024). Extracellular Vesicle (EV) Survivin for Cancer Diagnostics and Therapeutics: A Review. Frontiers in Bioscience-Landmark. 29(8). 302–302. 4 indexed citations
4.
Phyu, Su, et al.. (2024). Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders. Pharmaceuticals. 17(4). 426–426. 3 indexed citations
5.
Hou, Andrew J., Benjamin R. Uy, Begonya Comin-Anduix, et al.. (2024). IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma. Neuro-Oncology. 26(10). 1850–1866. 32 indexed citations
6.
Hatae, Ryusuke, Akane Yamamichi, Tiffany Chen, et al.. (2024). Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment. JCI Insight. 9(7). 27 indexed citations
7.
Gallus, Marco, et al.. (2024). A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives. Cells. 13(9). 726–726. 18 indexed citations
8.
Nejo, Takahide, Saritha Krishna, Akane Yamamichi, et al.. (2023). 956 Glioma-neuronal circuit remodeling induces regional immunosuppression. SHILAP Revista de lepidopterología. A1062–A1063. 1 indexed citations
9.
Nejo, Takahide, Saritha Krishna, Akane Yamamichi, et al.. (2023). CNSC-06. REDIRECTING IMMUNOSUPPRESSIVE GLIOMA MICROENVIRONMENT THROUGH PHARMACOLOGICAL INTERVENTION TARGETING NEURONAL ACTIVITY. Neuro-Oncology. 25(Supplement_5). v23–v23.
10.
Simic, Milos, Payal Watchmaker, Akane Yamamichi, et al.. (2023). 277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma. SHILAP Revista de lepidopterología. A317–A317. 1 indexed citations
11.
Parkes, Eileen E., Elaine S. Gilmore, Victoria Bingham, et al.. (2021). The clinical and molecular significance associated with STING signaling in breast cancer. npj Breast Cancer. 7(1). 81–81. 27 indexed citations
12.
Philippou, Yiannis, Hanna Sjoberg, Emma Murphy, et al.. (2020). Impacts of combining anti-PD-L1 immunotherapy and radiotherapy on the tumour immune microenvironment in a murine prostate cancer model. British Journal of Cancer. 123(7). 1089–1100. 49 indexed citations
14.
Phyu, Su, Chih‐Chung Tseng, & Timothy Smith. (2018). CDP-choline accumulation in breast and colorectal cancer cells treated with a GSK-3-targeting inhibitor. Magnetic Resonance Materials in Physics Biology and Medicine. 32(2). 227–235. 9 indexed citations
15.
Smith, Timothy, et al.. (2017). Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism. BioMed Research International. 2017. 1–7. 1 indexed citations
16.
Smith, Timothy & Su Phyu. (2016). Metformin Decouples Phospholipid Metabolism in Breast Cancer Cells. PLoS ONE. 11(3). e0151179–e0151179. 16 indexed citations
17.
Phyu, Su, Chih‐Chung Tseng, Ian N. Fleming, & Timothy Smith. (2016). Probing the PI3K/Akt/mTor pathway using 31P-NMR spectroscopy: routes to glycogen synthase kinase 3. Scientific Reports. 6(1). 36544–36544. 15 indexed citations
18.
Smith, Timothy, et al.. (2016). Effects of Administered Cardioprotective Drugs on Treatment Response of Breast Cancer Cells.. PubMed. 36(1). 87–93. 16 indexed citations
19.
Smith, Timothy & Su Phyu. (2016). Determination of Rate of [3H-methyl]-choline Incorporation into Cellular Lipids and Non-lipid Metabolites. BIO-PROTOCOL. 6(22). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026